Thus, the increased bone mass might be a synergistic effect of β2-AR deficiency (directly), β2-AR deficiency-associated increased body fat mass (reduced lipolysis) and serum leptin concentration (indirectly) as well as OA induction itself. The gene discussed is ADRB2; the disease is hyperinsulinemic hypoglycemia, familial, 4.